Screener
QuidelOrtho Corporation QDEL Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by QuidelOrtho Corporation in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: QuidelOrtho Corporation’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0001906324-26-000033
FAQ
- What is QuidelOrtho Corporation's cash & equivalents?
- QuidelOrtho Corporation (QDEL) reported cash & equivalents of $123.4M in Q2 2026.
- How has QuidelOrtho Corporation's cash & equivalents changed year-over-year?
- QuidelOrtho Corporation's cash & equivalents decreased by 18.7% year-over-year, from $151.7M to $123.4M.
- What is the long-term trend for QuidelOrtho Corporation's cash & equivalents?
- Over 4 years (2021 to 2025), QuidelOrtho Corporation's cash & equivalents has grown at a -32.2% compound annual growth rate (CAGR), from $802.8M to $169.8M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about QuidelOrtho Corporation's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude